Lapatinib

mitogen-activated protein kinase 14 ; Homo sapiens







7 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34159337 Discovery of pan-ErbB inhibitors protecting from SARS-CoV-2 replication, inflammation, and lung injury by a drug repurposing screen. 2021 Jun 15 1
2 29154981 Epidermal Growth Factor Receptor Family Inhibition Identifies P38 Mitogen-activated Protein Kinase as a Potential Therapeutic Target in Bladder Cancer. 2018 Feb 1
3 29387217 Effects of lapatinib on cell proliferation and apoptosis in NB4 cells. 2018 Jan 2
4 26063481 Lapatinib sensitizes quiescent MDA-MB-231 breast cancer cells to doxorubicin by inhibiting the expression of multidrug resistance-associated protein-1. 2015 Aug 2
5 26084280 PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim. 2015 Jun 19 1
6 22219388 Obatoclax and lapatinib interact to induce toxic autophagy through NOXA. 2012 Apr 1
7 18283037 Low-scale phosphoproteome analyses identify the mTOR effector p70 S6 kinase 1 as a specific biomarker of the dual-HER1/HER2 tyrosine kinase inhibitor lapatinib (Tykerb) in human breast carcinoma cells. 2008 Jun 1